Structure

Physi-Chem Properties

Molecular Weight:  436.12
Volume:  424.835
LogP:  3.399
LogD:  2.779
LogS:  -5.372
# Rotatable Bonds:  4
TPSA:  107.59
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.468
Synthetic Accessibility Score:  3.407
Fsp3:  0.208
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.861
MDCK Permeability:  5.5395437811966985e-05
Pgp-inhibitor:  0.974
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.219
Plasma Protein Binding (PPB):  78.96533966064453%
Volume Distribution (VD):  0.763
Pgp-substrate:  20.273977279663086%

ADMET: Metabolism

CYP1A2-inhibitor:  0.136
CYP1A2-substrate:  0.888
CYP2C19-inhibitor:  0.571
CYP2C19-substrate:  0.508
CYP2C9-inhibitor:  0.854
CYP2C9-substrate:  0.868
CYP2D6-inhibitor:  0.327
CYP2D6-substrate:  0.635
CYP3A4-inhibitor:  0.64
CYP3A4-substrate:  0.775

ADMET: Excretion

Clearance (CL):  5.03
Half-life (T1/2):  0.407

ADMET: Toxicity

hERG Blockers:  0.072
Human Hepatotoxicity (H-HT):  0.417
Drug-inuced Liver Injury (DILI):  0.975
AMES Toxicity:  0.457
Rat Oral Acute Toxicity:  0.525
Maximum Recommended Daily Dose:  0.195
Skin Sensitization:  0.708
Carcinogencity:  0.73
Eye Corrosion:  0.003
Eye Irritation:  0.204
Respiratory Toxicity:  0.048

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC14662

Natural Product ID:  NPC14662
Common Name*:   Kielcorin
IUPAC Name:   (2S,3S)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydro-[1,4]dioxino[2,3-c]xanthen-7-one
Synonyms:  
Standard InCHIKey:  LRBDQYXCSFVISO-FPOVZHCZSA-N
Standard InCHI:  InChI=1S/C24H20O8/c1-28-17-9-12(7-8-15(17)26)21-19(11-25)31-24-22-14(10-18(29-2)23(24)32-21)20(27)13-5-3-4-6-16(13)30-22/h3-10,19,21,25-26H,11H2,1-2H3/t19-,21-/m0/s1
SMILES:  COc1cc(ccc1O)[C@H]1[C@H](CO)Oc2c3c(cc(c2O1)OC)c(=O)c1ccccc1o3
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3813904
PubChem CID:   23242592
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0002699] Benzodioxanes
        • [CHEMONTID:0002704] Phenylbenzodioxanes
          • [CHEMONTID:0002707] Phenylbenzo-1,4-dioxanes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21963 Hypericum japonicum Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[11914965]
NPO40174 Kielmeyera variabilis Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[26900954]
NPO21963 Hypericum japonicum Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[27116034]
NPO21963 Hypericum japonicum Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[29667821]
NPO21963 Hypericum japonicum Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21963 Hypericum japonicum Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21963 Hypericum japonicum Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO21963 Hypericum japonicum Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 512.0 ug.mL-1 PMID[507578]
NPT1101 Organism Staphylococcus aureus subsp. aureus RN4220 Staphylococcus aureus subsp. aureus RN4220 MIC > 512.0 ug.mL-1 PMID[507578]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC14662 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9873 High Similarity NPC243877
0.9625 High Similarity NPC295082
0.9623 High Similarity NPC125039
0.9623 High Similarity NPC7154
0.9623 High Similarity NPC7688
0.9623 High Similarity NPC58223
0.9623 High Similarity NPC36916
0.9623 High Similarity NPC72787
0.9623 High Similarity NPC36
0.9568 High Similarity NPC81332
0.9568 High Similarity NPC262580
0.9568 High Similarity NPC289396
0.9568 High Similarity NPC271848
0.9568 High Similarity NPC212038
0.9557 High Similarity NPC113163
0.9557 High Similarity NPC66618
0.9557 High Similarity NPC165970
0.9557 High Similarity NPC288131
0.9557 High Similarity NPC84324
0.9557 High Similarity NPC305987
0.9557 High Similarity NPC158188
0.95 High Similarity NPC477840
0.9497 High Similarity NPC477841
0.9497 High Similarity NPC220912
0.9497 High Similarity NPC476247
0.9494 High Similarity NPC101731
0.949 High Similarity NPC99597
0.949 High Similarity NPC475267
0.949 High Similarity NPC210084
0.949 High Similarity NPC156057
0.949 High Similarity NPC474208
0.949 High Similarity NPC474836
0.949 High Similarity NPC162869
0.949 High Similarity NPC48208
0.9455 High Similarity NPC476618
0.9455 High Similarity NPC476620
0.9455 High Similarity NPC472387
0.9455 High Similarity NPC476619
0.9455 High Similarity NPC476622
0.9455 High Similarity NPC476621
0.9455 High Similarity NPC476623
0.9434 High Similarity NPC308992
0.9434 High Similarity NPC142252
0.9434 High Similarity NPC228383
0.943 High Similarity NPC284127
0.943 High Similarity NPC476410
0.943 High Similarity NPC172202
0.9427 High Similarity NPC255106
0.9427 High Similarity NPC235165
0.9427 High Similarity NPC472916
0.9398 High Similarity NPC185275
0.9398 High Similarity NPC324742
0.939 High Similarity NPC51774
0.939 High Similarity NPC236191
0.939 High Similarity NPC239549
0.9387 High Similarity NPC471416
0.9387 High Similarity NPC34287
0.9387 High Similarity NPC183357
0.9387 High Similarity NPC103307
0.9387 High Similarity NPC44558
0.9387 High Similarity NPC22195
0.9387 High Similarity NPC21190
0.9387 High Similarity NPC474434
0.9383 High Similarity NPC260266
0.9379 High Similarity NPC224280
0.9379 High Similarity NPC234052
0.9375 High Similarity NPC474034
0.9375 High Similarity NPC474033
0.9375 High Similarity NPC219927
0.9371 High Similarity NPC263449
0.9367 High Similarity NPC245758
0.9367 High Similarity NPC96167
0.9367 High Similarity NPC472914
0.9367 High Similarity NPC183851
0.9367 High Similarity NPC63454
0.9367 High Similarity NPC472911
0.9367 High Similarity NPC472913
0.9367 High Similarity NPC470402
0.9367 High Similarity NPC472910
0.9367 High Similarity NPC222814
0.9363 High Similarity NPC37392
0.9363 High Similarity NPC2928
0.9337 High Similarity NPC265380
0.9329 High Similarity NPC267254
0.9329 High Similarity NPC205076
0.9329 High Similarity NPC307518
0.9329 High Similarity NPC48773
0.9329 High Similarity NPC301683
0.9325 High Similarity NPC471457
0.9325 High Similarity NPC229687
0.9325 High Similarity NPC95855
0.9325 High Similarity NPC475212
0.9325 High Similarity NPC210042
0.9325 High Similarity NPC183036
0.9325 High Similarity NPC472383
0.9325 High Similarity NPC472381
0.9325 High Similarity NPC112755
0.9325 High Similarity NPC170675
0.9317 High Similarity NPC272064
0.9313 High Similarity NPC134783
0.9313 High Similarity NPC266314
0.9313 High Similarity NPC472632
0.9313 High Similarity NPC26326
0.9308 High Similarity NPC190487
0.9308 High Similarity NPC250214
0.9308 High Similarity NPC95936
0.9308 High Similarity NPC154304
0.9299 High Similarity NPC472915
0.9299 High Similarity NPC18727
0.9299 High Similarity NPC292214
0.9299 High Similarity NPC88645
0.9299 High Similarity NPC167091
0.9299 High Similarity NPC206238
0.9299 High Similarity NPC271779
0.9277 High Similarity NPC472992
0.9277 High Similarity NPC472991
0.9273 High Similarity NPC204693
0.9268 High Similarity NPC231194
0.9268 High Similarity NPC224462
0.9268 High Similarity NPC51326
0.9268 High Similarity NPC74559
0.9268 High Similarity NPC105511
0.9268 High Similarity NPC476365
0.9264 High Similarity NPC45400
0.9264 High Similarity NPC93099
0.9264 High Similarity NPC117854
0.9264 High Similarity NPC6588
0.9264 High Similarity NPC477154
0.9259 High Similarity NPC142614
0.9259 High Similarity NPC50960
0.9259 High Similarity NPC471788
0.9255 High Similarity NPC83922
0.9255 High Similarity NPC472448
0.925 High Similarity NPC471976
0.925 High Similarity NPC188967
0.925 High Similarity NPC174953
0.925 High Similarity NPC53889
0.9245 High Similarity NPC129684
0.9245 High Similarity NPC299520
0.9245 High Similarity NPC474055
0.9245 High Similarity NPC185526
0.9245 High Similarity NPC78225
0.9245 High Similarity NPC472598
0.9245 High Similarity NPC262286
0.9245 High Similarity NPC223787
0.9245 High Similarity NPC36852
0.9245 High Similarity NPC291508
0.9245 High Similarity NPC469584
0.9245 High Similarity NPC181960
0.9245 High Similarity NPC52530
0.9241 High Similarity NPC4455
0.9241 High Similarity NPC138360
0.9241 High Similarity NPC280339
0.9241 High Similarity NPC213622
0.9241 High Similarity NPC201136
0.9241 High Similarity NPC256612
0.9241 High Similarity NPC208197
0.9241 High Similarity NPC146165
0.9241 High Similarity NPC50715
0.9241 High Similarity NPC92659
0.9241 High Similarity NPC128863
0.9241 High Similarity NPC20830
0.9241 High Similarity NPC183597
0.9241 High Similarity NPC227325
0.9241 High Similarity NPC167815
0.9241 High Similarity NPC196439
0.9241 High Similarity NPC163780
0.9241 High Similarity NPC472909
0.9241 High Similarity NPC2476
0.9236 High Similarity NPC101996
0.9236 High Similarity NPC236637
0.9236 High Similarity NPC180234
0.9236 High Similarity NPC120537
0.9236 High Similarity NPC477231
0.9236 High Similarity NPC161277
0.9236 High Similarity NPC39007
0.9236 High Similarity NPC302950
0.9236 High Similarity NPC257648
0.9236 High Similarity NPC219582
0.9236 High Similarity NPC199100
0.9217 High Similarity NPC102028
0.9217 High Similarity NPC142996
0.9212 High Similarity NPC475155
0.9212 High Similarity NPC156977
0.9212 High Similarity NPC257667
0.9212 High Similarity NPC67134
0.9212 High Similarity NPC186847
0.9212 High Similarity NPC3583
0.9212 High Similarity NPC47140
0.9212 High Similarity NPC121333
0.9212 High Similarity NPC259152
0.9212 High Similarity NPC472386
0.9212 High Similarity NPC472454
0.9207 High Similarity NPC58053
0.9207 High Similarity NPC326877
0.9207 High Similarity NPC186807
0.9207 High Similarity NPC226294
0.9207 High Similarity NPC201292
0.9207 High Similarity NPC177480
0.9207 High Similarity NPC475942

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC14662 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9623 High Similarity NPD6168 Clinical (unspecified phase)
0.9623 High Similarity NPD6166 Phase 2
0.9623 High Similarity NPD6167 Clinical (unspecified phase)
0.9236 High Similarity NPD1934 Approved
0.9177 High Similarity NPD2801 Approved
0.9152 High Similarity NPD7074 Phase 3
0.9091 High Similarity NPD7054 Approved
0.9062 High Similarity NPD4868 Clinical (unspecified phase)
0.9057 High Similarity NPD2393 Clinical (unspecified phase)
0.9036 High Similarity NPD7472 Approved
0.8916 High Similarity NPD3818 Discontinued
0.8896 High Similarity NPD5494 Approved
0.8876 High Similarity NPD4338 Clinical (unspecified phase)
0.8869 High Similarity NPD6797 Phase 2
0.8869 High Similarity NPD7993 Clinical (unspecified phase)
0.8827 High Similarity NPD3882 Suspended
0.8817 High Similarity NPD7251 Discontinued
0.8765 High Similarity NPD7808 Phase 3
0.875 High Similarity NPD4380 Phase 2
0.8659 High Similarity NPD4381 Clinical (unspecified phase)
0.8639 High Similarity NPD5844 Phase 1
0.8608 High Similarity NPD1511 Approved
0.8537 High Similarity NPD3817 Phase 2
0.8503 High Similarity NPD6959 Discontinued
0.85 High Similarity NPD1512 Approved
0.8434 Intermediate Similarity NPD7075 Discontinued
0.8424 Intermediate Similarity NPD5402 Approved
0.8424 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8408 Intermediate Similarity NPD1549 Phase 2
0.8364 Intermediate Similarity NPD1465 Phase 2
0.8354 Intermediate Similarity NPD7411 Suspended
0.8344 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8343 Intermediate Similarity NPD6232 Discontinued
0.8323 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8304 Intermediate Similarity NPD7473 Discontinued
0.8253 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.821 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD6801 Discontinued
0.8171 Intermediate Similarity NPD6559 Discontinued
0.8165 Intermediate Similarity NPD2796 Approved
0.8156 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD7819 Suspended
0.814 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD1510 Phase 2
0.8037 Intermediate Similarity NPD6799 Approved
0.8 Intermediate Similarity NPD5403 Approved
0.7977 Intermediate Similarity NPD3926 Phase 2
0.7967 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7965 Intermediate Similarity NPD1247 Approved
0.7962 Intermediate Similarity NPD1613 Approved
0.7962 Intermediate Similarity NPD943 Approved
0.7962 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD1240 Approved
0.7943 Intermediate Similarity NPD3751 Discontinued
0.7895 Intermediate Similarity NPD3749 Approved
0.7892 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD5401 Approved
0.7877 Intermediate Similarity NPD8313 Approved
0.7877 Intermediate Similarity NPD8312 Approved
0.7862 Intermediate Similarity NPD1607 Approved
0.7857 Intermediate Similarity NPD6599 Discontinued
0.7844 Intermediate Similarity NPD1653 Approved
0.7841 Intermediate Similarity NPD7228 Approved
0.7836 Intermediate Similarity NPD7768 Phase 2
0.7816 Intermediate Similarity NPD3787 Discontinued
0.7805 Intermediate Similarity NPD6190 Approved
0.779 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD3027 Phase 3
0.7759 Intermediate Similarity NPD7199 Phase 2
0.7716 Intermediate Similarity NPD2935 Discontinued
0.7707 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD230 Phase 1
0.7683 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7672 Intermediate Similarity NPD6778 Approved
0.7672 Intermediate Similarity NPD6777 Approved
0.7672 Intermediate Similarity NPD6776 Approved
0.7672 Intermediate Similarity NPD6779 Approved
0.7672 Intermediate Similarity NPD6780 Approved
0.7672 Intermediate Similarity NPD6781 Approved
0.7672 Intermediate Similarity NPD6782 Approved
0.7644 Intermediate Similarity NPD6234 Discontinued
0.7644 Intermediate Similarity NPD919 Approved
0.7643 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD4628 Phase 3
0.7636 Intermediate Similarity NPD3750 Approved
0.7629 Intermediate Similarity NPD8151 Discontinued
0.7579 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD447 Suspended
0.7571 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD7685 Pre-registration
0.7558 Intermediate Similarity NPD37 Approved
0.7554 Intermediate Similarity NPD8150 Discontinued
0.7552 Intermediate Similarity NPD7696 Phase 3
0.7552 Intermediate Similarity NPD7435 Discontinued
0.7552 Intermediate Similarity NPD7697 Approved
0.7552 Intermediate Similarity NPD7698 Approved
0.7551 Intermediate Similarity NPD7783 Phase 2
0.7551 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD4967 Phase 2
0.7529 Intermediate Similarity NPD4966 Approved
0.7529 Intermediate Similarity NPD4965 Approved
0.7515 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD7870 Phase 2
0.7513 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD7871 Phase 2
0.75 Intermediate Similarity NPD1551 Phase 2
0.75 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7390 Discontinued
0.7487 Intermediate Similarity NPD7701 Phase 2
0.7485 Intermediate Similarity NPD3226 Approved
0.7484 Intermediate Similarity NPD4908 Phase 1
0.747 Intermediate Similarity NPD2800 Approved
0.7457 Intermediate Similarity NPD6844 Discontinued
0.7456 Intermediate Similarity NPD2533 Approved
0.7456 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD2534 Approved
0.7456 Intermediate Similarity NPD2532 Approved
0.7455 Intermediate Similarity NPD2344 Approved
0.7439 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD9494 Approved
0.7418 Intermediate Similarity NPD5953 Discontinued
0.7414 Intermediate Similarity NPD8455 Phase 2
0.7409 Intermediate Similarity NPD6823 Phase 2
0.7407 Intermediate Similarity NPD6535 Approved
0.7407 Intermediate Similarity NPD6534 Approved
0.7391 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD7700 Phase 2
0.7382 Intermediate Similarity NPD7699 Phase 2
0.7377 Intermediate Similarity NPD7240 Approved
0.7368 Intermediate Similarity NPD920 Approved
0.7366 Intermediate Similarity NPD8434 Phase 2
0.7362 Intermediate Similarity NPD1933 Approved
0.7353 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD7266 Discontinued
0.7337 Intermediate Similarity NPD7549 Discontinued
0.7333 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD3748 Approved
0.7323 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7874 Approved
0.7308 Intermediate Similarity NPD7286 Phase 2
0.7289 Intermediate Similarity NPD6099 Approved
0.7289 Intermediate Similarity NPD6100 Approved
0.7286 Intermediate Similarity NPD7801 Approved
0.7283 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2309 Approved
0.7278 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7259 Intermediate Similarity NPD7584 Approved
0.7251 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD2346 Discontinued
0.7243 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD6233 Phase 2
0.7229 Intermediate Similarity NPD2799 Discontinued
0.7225 Intermediate Similarity NPD4363 Phase 3
0.7225 Intermediate Similarity NPD4360 Phase 2
0.7212 Intermediate Similarity NPD6651 Approved
0.7182 Intermediate Similarity NPD5242 Approved
0.7178 Intermediate Similarity NPD6798 Discontinued
0.7178 Intermediate Similarity NPD2313 Discontinued
0.7175 Intermediate Similarity NPD5353 Approved
0.7173 Intermediate Similarity NPD6212 Phase 3
0.7173 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD6213 Phase 3
0.7167 Intermediate Similarity NPD8127 Discontinued
0.716 Intermediate Similarity NPD6832 Phase 2
0.716 Intermediate Similarity NPD1243 Approved
0.7135 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7033 Discontinued
0.7118 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7680 Approved
0.7099 Intermediate Similarity NPD2861 Phase 2
0.7097 Intermediate Similarity NPD7039 Approved
0.7097 Intermediate Similarity NPD7038 Approved
0.7086 Intermediate Similarity NPD7458 Discontinued
0.7081 Intermediate Similarity NPD1203 Approved
0.7077 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD8320 Phase 1
0.7071 Intermediate Similarity NPD8319 Approved
0.7053 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1610 Phase 2
0.7033 Intermediate Similarity NPD5711 Approved
0.7033 Intermediate Similarity NPD7229 Phase 3
0.7033 Intermediate Similarity NPD5710 Approved
0.7016 Intermediate Similarity NPD4287 Approved
0.7006 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6385 Approved
0.7006 Intermediate Similarity NPD6386 Approved
0.7 Intermediate Similarity NPD2424 Discontinued
0.7 Intermediate Similarity NPD9269 Phase 2
0.6971 Remote Similarity NPD7907 Approved
0.6959 Remote Similarity NPD1652 Phase 2
0.6957 Remote Similarity NPD2899 Discontinued
0.6957 Remote Similarity NPD4111 Phase 1
0.6957 Remote Similarity NPD4665 Approved
0.6957 Remote Similarity NPD7784 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data